Search


PDF Archive search engine
Last database update: 11 May at 16:12 - Around 76000 files indexed.


Show results per page

Results for «melanoma»:


Total: 33 results - 0.058 seconds

melanoma 100%

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Melanoma Version 1.2017 — November 10, 2016 NCCN.org NCCN Guidelines for Patients® available at www.nccn.org/patients Continue Version 1.2017, 11/10/16 © National Comprehensive Cancer Network, Inc.

https://www.pdf-archive.com/2017/05/08/melanoma/

08/05/2017 www.pdf-archive.com

ER1107 84%

Break 17.00 Tumor board lung cancer Wednesday Immunology Melanoma and sarcoma Thursday Colorectal Interesting cases from audience 09:30 - 10:30 Basics of Immunology:

https://www.pdf-archive.com/2018/09/11/er1107/

11/09/2018 www.pdf-archive.com

ER1198 66%

Melanoma and Non Melanoma Skin Cancer an update Prof Dr.

https://www.pdf-archive.com/2019/04/02/er1198/

02/04/2019 www.pdf-archive.com

CV 62%

Studio dei meccanismi molecolari attraverso cui l’endotelina modula la crescita, la sopravvivenza, l’invasività cellulare e l’angiogenesi di tumori, quali il melanoma e il carcinoma dell’ovaio, con particolare riguardo all’identificazione di un nuovo bersaglio molecolare antitumorale:

https://www.pdf-archive.com/2017/09/14/cv/

14/09/2017 www.pdf-archive.com

Relatório 60%

O paciente já tinha dado entrada no HCV no mês de janeiro e, na data, foi diagnosticado melanoma na região cervical e várias metástases pulmonares.

https://www.pdf-archive.com/2014/07/01/relat-rio/

30/06/2014 www.pdf-archive.com

link-a-video-to-your-campaign-page 60%

• The survival rate for Melanoma is 98% when caught early.

https://www.pdf-archive.com/2016/11/11/link-a-video-to-your-campaign-page/

11/11/2016 www.pdf-archive.com

ER1028 58%

Hospital Universitario Son Espases, Palma de Mallorca 13.00 - 13.20h 13.20 - 13.40h 13.40 - 14.00h Registro de melanoma avanzado Dr.

https://www.pdf-archive.com/2018/06/13/er1028/

13/06/2018 www.pdf-archive.com

M.Garbolino CV 57%

I was selected with the project Neo, a low-cost tool for skin self-examination, to early detect Melanoma.

https://www.pdf-archive.com/2018/05/09/mgarbolinocv/

09/05/2018 www.pdf-archive.com

DonorIntakeEnglish012715 57%

____________ Heart Problems (yourself or family): ____________________________________________________________ Any history of melanoma?:

https://www.pdf-archive.com/2016/12/13/donorintakeenglish012715/

13/12/2016 www.pdf-archive.com

2017 June GCTC Newsletter 56%

I am now paying the price, from pre-cancerous growths to melanoma.

https://www.pdf-archive.com/2017/08/09/2017-june-gctc-newsletter/

09/08/2017 www.pdf-archive.com

CCE Meeting Program v7 56%

adjuvant treatment of melanoma The Karolinska prostate cancer liquid biopsy program Discussion AstraZeneca speaker TBD Duncan Jodrell (CCC) Charles Ferté (GR) Ferdia Gallagher (CCC) Alexander van Akkooi (NKI) Short talk - Johan Lindberg (KI) 12:30 - 1:30 PM 1:30 - 2:20 PM 01:30 01:45 02:00 2:10 - 2:20 PM 2:20 PM 02:50 - 4:00 PM 02:50 03:05 03:20 03:35 3:45 - 4:00 PM 4 - 4:15 PM 4:15 PM Lunch Break SESSION 4:

https://www.pdf-archive.com/2016/12/22/cce-meeting-program-v7/

22/12/2016 www.pdf-archive.com

Download Swog Fall 2012 Group Meeting PDF 54%

86-89 Melanoma Committee...........................................................................................................................................15 &

https://www.pdf-archive.com/2018/08/22/download-swog-fall-2012-group-meeting-pdf/

22/08/2018 www.pdf-archive.com

ONM Declaration 53%

“It also prevents melanoma” [1] 23 - SandyLovesYous:

https://www.pdf-archive.com/2011/01/11/onm-declaration/

11/01/2011 www.pdf-archive.com

igrandangolo prog 2018 pp 52%

Ascierto, Umberto Malapelle Discussione interattiva Take home messages Paolo Marchetti Take home messages Paolo Marchetti 18.40 Il melanoma:

https://www.pdf-archive.com/2018/11/09/igrandangoloprog2018pp/

09/11/2018 www.pdf-archive.com

CTC-Microfluidic-Chip Amir Shahein Loic Chaubet 50%

Splenic immune cells from either IRF-8 knockout or wild type mice were cultured in a microfluidic environment connected to a group of aggressive melanoma cells (B16 cells).

https://www.pdf-archive.com/2018/04/09/ctc-microfluidic-chip-amir-shahein-loic-chaubet/

09/04/2018 www.pdf-archive.com

2002 July 50%

But how many of us lcrow how the inspiring talk by Jill Shamban, the Executive cope with nearby lightning and storms coming Director of the Richard David Kann Melanoma foundation.

https://www.pdf-archive.com/2018/03/05/2002-july/

05/03/2018 www.pdf-archive.com

2826 Pathology Meeting program 48%

Enrique de Álava Casado, Hospital Virgen del Rocío, Seville, Spain Targeted therapies and immunotherapy in melanoma.

https://www.pdf-archive.com/2018/08/08/2826pathology-meetingprogram/

08/08/2018 www.pdf-archive.com

2534 - MD Anderson Cancer Center Madrid- Pathology Meeting - program 45%

Houston, USA 15:00 - 15:45 Utility of molecular pathology techniques in the diagnosis of melanoma Dr.

https://www.pdf-archive.com/2018/06/18/untitled-pdf-document/

18/06/2018 www.pdf-archive.com

June - July 2017 134 44%

While excessive exposure to the sun’s UV rays in the first 10 years certainly increases your risk of melanoma, what happens after this is also very important.

https://www.pdf-archive.com/2017/06/14/june-july-2017-134/

14/06/2017 www.pdf-archive.com

AncientCancer 43%

According to 2013 Canadian Cancer Statistics, an estimated 187,600 new cases of cancer (excluding about 81,000 non-melanoma skin cancers) will be diagnosed and 75,000 deaths will occur in 20133.

https://www.pdf-archive.com/2014/04/05/ancientcancer/

04/04/2014 www.pdf-archive.com

Chemo 42%

551 CYTOTOXIC CHEMOTHERAPY SURVIVAL IN ADULT MALIGNANCIES Table 1 e Impact of cytotoxic chemotherapy on 5-year survival in Australian adults Malignancy Head and neck Oesophagus Stomach Colon Rectum Pancreas Lung Soft tissue sarcoma Melanoma of skin Breast Uterus Cervix Ovary Prostate Testis Bladder Kidney Brain Unknown primary site Non-Hodgkin’s lymphoma Hodgkin’s disease Multiple myeloma ICD-9 140e149, 160, 161 150 151 153 154 157 162 171 172 174 179 C 182 180 183 185 186 188 189 191 195e199 200 C 202 201 203 Total Number of cancers in people aged O20 years* Absolute number of 5-year survivors due to chemotherapyy 2486 1003 1904 7243 4036 1728 7792 665 7811 10 661 1399 867 1207 9869 529 2802 2176 1116 3161 3145 341 1023 63 54 13 128 218 e 118 e e 164 e 104 105 e 221 e e 55 e 331 122 e 72 903x 1690 Percentage 5-year survivors due to chemotherapyz 2.5 4.8 0.7 1.8 5.4 e 1.5 e e 1.5 e 12 8.7 e 41.8 e e 4.9 e 10.5 35.8 e 2.3% *Numbers from Ref.

https://www.pdf-archive.com/2016/07/19/chemo/

19/07/2016 www.pdf-archive.com

Kasi - Vittal Poster - Final 42%

Vemurafenib is a potent inhibitor of the kinase domain in mutant BRAF, which prolongs progression-free and overall survival in melanoma patients with BRAF mutation but its use in BRAF mutated colon cancer is not well established.

https://www.pdf-archive.com/2016/04/29/kasi-vittal-poster-final/

29/04/2016 www.pdf-archive.com

Kaye 42%

Cellular Medicine Board) Member of Scottish Breast Cancer Trials Group Member of Scottish Urology Group Treasurer of West of Scotland Lung Cancer Group Member of Cancer Advisory Group/Clinical Effectiveness Group, Greater Glasgow Health Board Secretary of West of Scotland Oncological Organisation Chairman West of Scotland Oncological Organization Member of Scottish Gynae Cancer Trials Group (Chairman 1986-1996) Member of Scottish Melanoma Group Member of Scottish Cancer Co-ordinating and Advisory Committee Grant Holder, Scottish Cancer Therapy Network Member of Oncology Board of Academy of Scottish Royal Colleges e) UKCCCR 1985-1992 1990-1995 1999-2001 Member of Gynaecological Cancer Group Member of Main Committee Chairman of Testicular Cancer Group f) NCRN/I 2001-2009 Member of National Cancer Research Network/Institute Steering Group.

https://www.pdf-archive.com/2018/03/19/kaye/

19/03/2018 www.pdf-archive.com

An Overview of Basal Cell Carcinoma 40%

In addition, BCC accounts for approximately 75% of all non-melanoma skin cancers (Nakayama et al.

https://www.pdf-archive.com/2013/02/24/an-overview-of-basal-cell-carcinoma/

24/02/2013 www.pdf-archive.com

May June 2017 (1) 38%

Krauss will discuss the use of immunotherapy in melanoma, kidney cancer, lung cancer, bladder cancer, and Hodgkin’s lymphoma, as well as speculation for new uses of these medications.

https://www.pdf-archive.com/2017/04/24/may-june-2017-1/

24/04/2017 www.pdf-archive.com